- |||||||||| lexaptepid pegol (NOX H94) / TME Pharma
Enrollment change, Trial primary completion date: Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients (clinicaltrials.gov) - Dec 5, 2014 P1/2, N=32, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015 N=20 --> 32 | Trial primary completion date: Nov 2014 --> Aug 2015
|